Bioventus Inc. balance sheet BVS

Annual Quarterly

As of Sep 26, 2026, Bioventus Inc. had total assets of $673.4 million and total liabilities of $381.6 million. Total assets were down 4.0% from a year earlier. Stockholders' equity was $240.5 million. It held $34.1 million in cash and investments against $244.2 million of total debt, net debt of $210.0 million. The current ratio, current assets divided by current liabilities, was 1.68.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2026
Sep 26, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Assets
Cash
31
-27.2%
51
+23.2%
42
+12.5%
37
+22.5%
30
-31.3%
44
Long-term investments
3
+50.3%
2
+21.2%
2
-39.8%
3
+19.8%
3
-91.1%
29
Cash and investments
34
-23.2%
54
+23.1%
43
+8.4%
40
+22.2%
33
-55.2%
73
Receivables
138
+6.0%
128
+0.7%
127
+3.7%
123
-9.9%
136
+9.1%
125
Inventory
83
-13.7%
82
-11.1%
92
+1.3%
91
+7.7%
85
+37.4%
62
Total current assets
266
-5.5%
273
-1.0%
276
+2.8%
268
-1.7%
273
+3.6%
263
Property and equipment, net
20
-13.9%
22
-18.9%
27
-26.2%
37
+33.3%
27
—
Goodwill
7
+0.0%
7
+0.0%
7
+0.0%
7
+0.0%
7
-94.9%
148
Total assets
673
-4.0%
684
-6.1%
728
-10.2%
811
-40.9%
1,373
+12.0%
1,226
Liabilities and equity
Accounts payable
26
-3.2%
11
-53.9%
24
+2.8%
23
-37.2%
37
+116.9%
17
Total current liabilities
158
-2.5%
160
-23.8%
210
+19.9%
175
-42.3%
304
+68.1%
181
Total liabilities
382
-22.8%
455
-16.1%
542
-8.0%
590
-38.6%
960
+55.4%
618
Stockholders' equity
240
+44.8%
184
+24.4%
148
-14.8%
174
-46.6%
325
-29.1%
459
Debt
Debt due within a year
19
+66.7%
15
-45.1%
27
-1.8%
28
-15.8%
33
+83.3%
18
Long-term debt
211
-32.2%
279
-9.5%
308
-16.0%
367
-4.7%
385
+13.4%
340
Lease liabilities
14
-22.9%
17
-14.8%
20
-20.7%
26
+43.9%
18
-3.4%
19
Total debt
244
-28.4%
311
-12.6%
356
-15.4%
421
-3.5%
436
+15.9%
376
Net cash
-210
+29.2%
-258
+17.5%
-313
+17.9%
-381
+5.6%
-403
-33.1%
-303
Ratios
Current ratio
1.68x
1.70x
1.31x
1.53x
0.90x
1.45x
Debt to equity
1.02x
1.69x
2.41x
2.42x
1.34x
0.82x
Debt to EBITDA
2.42x
3.08x
10.36x
—
—
8.02x
Return on equity
23.82%
12.35%
-24.42%
-90.00%
-48.80%
4.22%
Return on assets
8.51%
3.33%
-4.96%
-19.27%
-11.56%
1.58%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BVS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Accelerated filer, Emerging growth company
SEC CIK
1665988

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.